regorafenib cost stivarga cost


Posted August 22, 2018 by mildasmoser

Regonix(Stivarga)is a kinase inhibitor indicated for the treatment of patients with:

 
Regonix(Stivarga)is a kinase inhibitor indicated for the treatment of patients with: Metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an antiVEGF therapy, and, if RAS wild-type, an anti-EGFR therapy. Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

Regonix’s brand name is Stivarga® by Bayer. Regonix is a kinase inhibitor from Beacon, which is one of the biggest pharmaceutical company in Bangladesh.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By thomas shaw
Website regorafenib cost stivarga cost
Business Address Los Angels
Country United States
Categories Business
Last Updated August 22, 2018